156 related articles for article (PubMed ID: 7290269)
1. Clinical usefulness of serum acute-phase reactants in patients with ovarian tumors.
Warwas M; Dobryszycka W; Gerber J; Pietkiewicz A
Neoplasma; 1981; 28(4):485-90. PubMed ID: 7290269
[TBL] [Abstract][Full Text] [Related]
2. Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.
Dobryszycka W; Gerber J; Zuwała-Jagiełło J; Ujec M
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):41-50. PubMed ID: 1725104
[TBL] [Abstract][Full Text] [Related]
3. Haptoglobin and proteinase inhibitors in the blood serum of women with inflammatory, benign and neoplastic lesions of the ovary.
Warwas M; Gerber J; Pietkiewicz A
Neoplasma; 1986; 33(1):79-84. PubMed ID: 2421174
[TBL] [Abstract][Full Text] [Related]
4. Changes of serum proteins in patients with malignant gynaecological tumours.
Pulay T; Csömör S; Kovács I; Szarka G; Somos P
Acta Chir Hung; 1988; 29(4):305-14. PubMed ID: 3266407
[TBL] [Abstract][Full Text] [Related]
5. Serum haptoglobin, CA 125 and interleukin 6 levels in malignant and non-malignant tumors of the ovary.
Dobryszycka W; Katnik-Prastowska I; Gerber J; Lemańska K; Utko K; Rozdolski K
Arch Immunol Ther Exp (Warsz); 1999; 47(4):229-36. PubMed ID: 10483871
[TBL] [Abstract][Full Text] [Related]
6. Preoperative serum thrombopoietin levels are higher in patients with ovarian cancer than with benign cysts.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):67-70. PubMed ID: 16359773
[TBL] [Abstract][Full Text] [Related]
7. [Factors of the "acute phase" in proliferative diseases of the hemopoietic system].
Szela S
Wiad Lek; 1992 Sep; 45(17-18):659-64. PubMed ID: 1295250
[TBL] [Abstract][Full Text] [Related]
8. Changes in insulin-like growth factor I, 17-b-estradiol, and progesterone in postmenopausal women with benign and malignant ovarian tumours.
Waksmański B; Dudkiewicz J; Kowalski T
Med Sci Monit; 2001; 7(5):919-23. PubMed ID: 11535935
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
11. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors].
Li L; Wang LM; Zhang W; Zhang JQ; Song HL; Yao DS; Tang Y; Chen XQ; Yang ZH
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):72-6. PubMed ID: 12783691
[TBL] [Abstract][Full Text] [Related]
12. Acute phase reactant proteins in differential diagnosis of monoclonal gammopathy.
San Miguel J; Corrales A; Alberca I; Vicente V; Lopez Borrasca A
Neoplasma; 1983; 30(1):57-62. PubMed ID: 6403877
[TBL] [Abstract][Full Text] [Related]
13. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
[TBL] [Abstract][Full Text] [Related]
14. Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.
Ott HW; Lindner H; Sarg B; Mueller-Holzner E; Abendstein B; Bergant A; Fessler S; Schwaerzler P; Zeimet A; Marth C; Illmensee K
Cancer Res; 2003 Nov; 63(21):7507-14. PubMed ID: 14612552
[TBL] [Abstract][Full Text] [Related]
15. Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients.
Hefler L; Tempfer C; Heinze G; Mayerhofer K; Breitenecker G; Leodolter S; Reinthaller A; Kainz C
Br J Cancer; 1999 Nov; 81(5):855-9. PubMed ID: 10555758
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
17. Significance of the O6-methylguanine-DNA methyltransferase and glutathione S-transferase activity in the sera of patients with malignant and benign ovarian tumors.
Akçay T; Dinçer Y; Alademir Z; Aydinli K; Arvas M; Demirkiran F; Kösebay D
Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):108-13. PubMed ID: 15734094
[TBL] [Abstract][Full Text] [Related]
18. Haptoglobin types in ovarian tumors.
Dobryszycka W; Warwas M
Neoplasma; 1983; 30(2):169-72. PubMed ID: 6843722
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
Peng XP; Li JD; Li MD; Ye XM; Yan WC
Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
[TBL] [Abstract][Full Text] [Related]
20. Reference levels of acute phase reactant proteins in healthy Zairean women in the reproductive age group.
Kuvibidila S; Warrier RP; Yu L; Ode D; Mbele V
J Trop Med Hyg; 1994 Aug; 97(4):239-43. PubMed ID: 8064948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
